Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Apr;41(4):707-714.
doi: 10.1007/s00296-021-04797-4. Epub 2021 Feb 9.

The impact of COVID-19 on rheumatology patients in a large UK centre using an innovative data collection technique: prevalence and effect of social shielding

Affiliations

The impact of COVID-19 on rheumatology patients in a large UK centre using an innovative data collection technique: prevalence and effect of social shielding

N Cleaton et al. Rheumatol Int. 2021 Apr.

Abstract

Objectives: We sought to gain insight into the prevalence of COVID-19 and the impact stringent social distancing (shielding) has had on a large cohort of rheumatology (RD) follow-up patients from a single large UK centre.

Methods: We linked COVID-19-related deaths, screening and infection rates to our RD population (1.2.20-1.5.20) and audited active rheumatology follow-up patients through survey data communicated via a linked mobile phone SMS message. We assessed epidemiology, effect of stringent social distancing (shielding) and quality of life (HRQoL) by Short Form 12 (SF12).

Results: There were 10,387 active follow-up patients, 7911 had linked mobile numbers. 12/10,387 RD patients died from COVID-19 (0.12%); local population 4131/7,415,149 (0.12%). For patients with mobile phones, 1693/7911 (21%) responded and of these, 1605 completed the SF12. Inflammatory arthritis predominated 1174/1693 (69%); 792/1693 (47%) were shielding. Advice on shielding/distancing was followed by 1372/1693(81%). 61/1693 (4%) reported COVID-19 (24/61 shielding); medication distribution was similar in COVID and non-COVID patients. Mental SF12 (MCS) but not physical (PCS) component scores were lower in COVID (60) vs. non-COVID (1545), mean differences: MCS, - 3.3; 95% CI - 5.2 to - 1.4, P < 0.001; PCS, - 0.4; 95% CI, - 2.1 to 1.3). In 1545 COVID-negative patients, those shielding had lower MCS (- 2.1; 95% CI - 2.8 to - 1.4) and PCS (- 3.1, 95% CI - 3.7 to - 2.5), both P < 0.001.

Conclusions: Our full RD cohort had no excess of COVID deaths compared to the general local population. Our survey data suggest that shielding adversely affects both mental and physical health in RD. These data broaden our understanding of shielding, indicating need for further study.

Keywords: COVID-19; Health care delivery; Health service research; Quality improvement; Quality of life indicators; Rheumatic disease.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Comment in

References

    1. EULAR. (2020) Policy statement on COVID-19. Available from: https://www.eular.org/eular_guidance_for_patients_covid19_outbreak.cfm. Accessed 20 May 2020.
    1. British Society for Rheumatology. (2020) COVID-19 (Coronavirus)-update for members. Available from: https://www.rheumatology.org.uk/news-policy/details/covid19-coronavirus-.... Accessed 25 May 2020.
    1. Price E, MacPhie E, Kay L, Lanyon P, Griffiths B, Holroyd C, Abhishek A, Youngstein T, Bailey K, Clinch J, Shaikh M, Rivett A. Identifying rheumatic disease patients at high risk and requiring shielding during the COVID19 pandemic. Clin Med (London, England) 2020 doi: 10.7861/clinmed.2020-0160. - DOI - PMC - PubMed
    1. Public Health England. (2020) Guidance on shielding and protecting people defined on medical grounds as extremely vulnerable from COVID-19. Available from: https://www.gov.uk/government/publications/guidance-on-shielding-and-pro.... Accessed 25 May 2020.
    1. Bateman J, Mulherin D, Hirsch G, Venkatachalam S, Sheeran T. Rapid distribution of information by SMS-embedded video link to patients during a pandemic. Lancet Rheumatol. 2020 doi: 10.1016/S2665-9913(20)30126-0. - DOI - PMC - PubMed